1. In Vitro
Activities and Spectrum of the Novel Fluoroquinolone Lascufloxacin (KRP-AM1977)
2. Totsuka K, Odajima M, Nakauchi M, Sesoko S, Nakashima M. 2016. Phase I study to determine the safety and pharmacokinetics (PK) of single and multiple oral doses of lascufloxacin (AM-1977) in healthy subjects, abstr SUNDAY-467. Abstr ASM Microbe, 16 to 20 June 2016, Boston, MA.
3. Kishii R, Yamamuro N, Yamaguchi Y, Abukawa H, Takei M. 2016. In vivo bactericidal activity of lascufloxacin (AM-1977), a newly developed fluoroquinolone, against mouse pulmonary infection model caused by Streptococcus pneumoniae, abstr SUNDAY-471. Abstr ASM Microbe, 16 to 20 June 2016, Boston, MA.
4. Totsuka K, Odajima M, Nakauchi M, Sesoko S, Nakashima M. 2016. Phase I study to determine the safety and pharmacokinetics (PK) of single and multiple intravenous infusion of lascufloxacin (AM-1977) in healthy subjects, abstr SUNDAY-470. Abstr ASM Microbe, 16 to 20 June 2016, Boston, MA.
5. Pulmonary disposition of antimicrobial agents: methodological considerations